BECKHAM
24-02-2022, 03:00 PM
Crizanlizumab is thought to cut visits to A&E by 40% for patients with the blood disorder.
for more .... (https://www.bbc.co.uk/news/health-60498916?at_medium=RSS&at_campaign=KARANGA)
for more .... (https://www.bbc.co.uk/news/health-60498916?at_medium=RSS&at_campaign=KARANGA)